Chlorotrianisene

From Wikipedia, the free encyclopedia
Chlorotrianisene
Systematic (IUPAC) name
1,1',1''-(2-chloroethene-1,1,2-triyl)tris(4-methoxybenzene)
Clinical data
Trade names Tace
AHFS/Drugs.com Multum Consumer Information
Pregnancy cat. X (US)
Legal status Discontinued
Routes Oral
Pharmacokinetic data
Protein binding 50 to 80%
Identifiers
CAS number 569-57-3 YesY
ATC code G03CA06
PubChem CID 11289
DrugBank DB00269
ChemSpider 10815 YesY
UNII 6V5034L121 YesY
KEGG D00269 YesY
ChEBI CHEBI:3641 YesY
ChEMBL CHEMBL1200761 N
Chemical data
Formula C23H21ClO3 
Mol. mass 380.864 g/mol
 N (what is this?)  (verify)

Chlorotrianisene (trade name Tace) is a non-steroidal synthetic estrogen that was formerly used for the treatment of menopause, deficiencies in ovary function, and prostate cancer.[1][2]

References

  1. Drugs.com: Chlorotrianisene
  2. Yuen, B. H.; Pendleton, H. J.; Blair, S. (1977). "Efficacy of bromocriptine and chlorotrianisene in preventing postpartum lactation". Canadian Medical Association journal 117 (8): 919–921. PMC 1880136. PMID 334356. 



This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.